Spontaneous mutations in the HBV genome and their clinical implications

Pejman G. Mansourian, Marc G. Ghany, Emmanuel Thomas

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

Chronic hepatitis B infection remains a significant cause of morbidity and mortality worldwide despite the availability of an effective vaccine. The clinical management of chronic hepatitis B infection is complex often requiring the use of nucleotide analogs as well as immune modulators. The natural history and response to therapy are affected by the presence of naturally occurring mutations in the HBV genome particularly those in the basal core promoter and precore sites. Understanding the role of these mutations in outcome of infection and response to therapy can enable physicians to customize management in order to achieve optimal clinical outcomes.

Original languageEnglish
Pages (from-to)79-87
Number of pages9
JournalCurrent Hepatitis Reports
Volume12
Issue number2
DOIs
StatePublished - Jun 1 2013

Fingerprint

Chronic Hepatitis B
Genome
Mutation
Infection
Natural History
Vaccines
Nucleotides
Morbidity
Physicians
Mortality
Therapeutics

Keywords

  • Hepatitis
  • Liver cancer
  • Mutations
  • Virus

ASJC Scopus subject areas

  • Hepatology
  • Virology

Cite this

Spontaneous mutations in the HBV genome and their clinical implications. / Mansourian, Pejman G.; Ghany, Marc G.; Thomas, Emmanuel.

In: Current Hepatitis Reports, Vol. 12, No. 2, 01.06.2013, p. 79-87.

Research output: Contribution to journalArticle

Mansourian, Pejman G. ; Ghany, Marc G. ; Thomas, Emmanuel. / Spontaneous mutations in the HBV genome and their clinical implications. In: Current Hepatitis Reports. 2013 ; Vol. 12, No. 2. pp. 79-87.
@article{475137d7972f4b03a8842d95556f9c5c,
title = "Spontaneous mutations in the HBV genome and their clinical implications",
abstract = "Chronic hepatitis B infection remains a significant cause of morbidity and mortality worldwide despite the availability of an effective vaccine. The clinical management of chronic hepatitis B infection is complex often requiring the use of nucleotide analogs as well as immune modulators. The natural history and response to therapy are affected by the presence of naturally occurring mutations in the HBV genome particularly those in the basal core promoter and precore sites. Understanding the role of these mutations in outcome of infection and response to therapy can enable physicians to customize management in order to achieve optimal clinical outcomes.",
keywords = "Hepatitis, Liver cancer, Mutations, Virus",
author = "Mansourian, {Pejman G.} and Ghany, {Marc G.} and Emmanuel Thomas",
year = "2013",
month = "6",
day = "1",
doi = "10.1007/s11901-013-0170-x",
language = "English",
volume = "12",
pages = "79--87",
journal = "Current Hepatitis Reports",
issn = "1540-3416",
publisher = "Springer Publishing Company",
number = "2",

}

TY - JOUR

T1 - Spontaneous mutations in the HBV genome and their clinical implications

AU - Mansourian, Pejman G.

AU - Ghany, Marc G.

AU - Thomas, Emmanuel

PY - 2013/6/1

Y1 - 2013/6/1

N2 - Chronic hepatitis B infection remains a significant cause of morbidity and mortality worldwide despite the availability of an effective vaccine. The clinical management of chronic hepatitis B infection is complex often requiring the use of nucleotide analogs as well as immune modulators. The natural history and response to therapy are affected by the presence of naturally occurring mutations in the HBV genome particularly those in the basal core promoter and precore sites. Understanding the role of these mutations in outcome of infection and response to therapy can enable physicians to customize management in order to achieve optimal clinical outcomes.

AB - Chronic hepatitis B infection remains a significant cause of morbidity and mortality worldwide despite the availability of an effective vaccine. The clinical management of chronic hepatitis B infection is complex often requiring the use of nucleotide analogs as well as immune modulators. The natural history and response to therapy are affected by the presence of naturally occurring mutations in the HBV genome particularly those in the basal core promoter and precore sites. Understanding the role of these mutations in outcome of infection and response to therapy can enable physicians to customize management in order to achieve optimal clinical outcomes.

KW - Hepatitis

KW - Liver cancer

KW - Mutations

KW - Virus

UR - http://www.scopus.com/inward/record.url?scp=84878755581&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84878755581&partnerID=8YFLogxK

U2 - 10.1007/s11901-013-0170-x

DO - 10.1007/s11901-013-0170-x

M3 - Article

AN - SCOPUS:84878755581

VL - 12

SP - 79

EP - 87

JO - Current Hepatitis Reports

JF - Current Hepatitis Reports

SN - 1540-3416

IS - 2

ER -